Research Analysts’ Recent Ratings Changes for Stryker (SYK)

A number of research firms have changed their ratings and price targets for Stryker (NYSE: SYK):

• 1/6/2026 – Stryker was upgraded by analysts at Raymond James Financial, Inc. from a “market perform” rating to an “outperform” rating. They now have a $418.00 price target on the stock.
• 1/5/2026 – Stryker was given a new $390.00 price target on by analysts at Evercore ISI.
• 12/22/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/21/2025 – Stryker was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/19/2025 – Stryker was upgraded by analysts at Citizens Jmp from a “market perform” rating to an “outperform” rating. They now have a $440.00 price target on the stock.
• 12/18/2025 – Stryker had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $392.00. They now have a “hold” rating on the stock.
• 12/15/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/13/2025 – Stryker was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/11/2025 – Stryker had its price target lowered by analysts at Citigroup Inc. from $455.00 to $420.00. They now have a “buy” rating on the stock.
• 12/8/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – Stryker had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $435.00 price target on the stock.
• 11/14/2025 – Stryker had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $448.00 price target on the stock.
• 11/14/2025 – Stryker had its price target raised by analysts at Truist Financial Corporation from $392.00 to $400.00. They now have a “hold” rating on the stock.
• 11/14/2025 – Stryker had its price target raised by analysts at Wells Fargo & Company from $452.00 to $456.00. They now have an “overweight” rating on the stock.
• 11/14/2025 – Stryker had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $410.00 price target on the stock.
• 11/13/2025 – Stryker had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.

Stryker Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This is a positive change from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio is currently 46.25%.

Insider Activity at Stryker

In other news, CFO Preston Wendell Wells sold 165 shares of the firm’s stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $365.88, for a total transaction of $60,370.20. Following the completion of the transaction, the chief financial officer directly owned 6,694 shares in the company, valued at $2,449,200.72. This trade represents a 2.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of the stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $365.49, for a total transaction of $713,801.97. Following the completion of the sale, the chief accounting officer directly owned 2,833 shares in the company, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 522,118 shares of company stock worth $185,381,932 in the last three months. Company insiders own 5.20% of the company’s stock.

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.